Fuwu Zhang

7.9k total citations · 1 hit paper
94 papers, 6.7k citations indexed

About

Fuwu Zhang is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Fuwu Zhang has authored 94 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Biomaterials, 37 papers in Biomedical Engineering and 36 papers in Molecular Biology. Recurrent topics in Fuwu Zhang's work include Nanoplatforms for cancer theranostics (31 papers), Nanoparticle-Based Drug Delivery (29 papers) and RNA Interference and Gene Delivery (18 papers). Fuwu Zhang is often cited by papers focused on Nanoplatforms for cancer theranostics (31 papers), Nanoparticle-Based Drug Delivery (29 papers) and RNA Interference and Gene Delivery (18 papers). Fuwu Zhang collaborates with scholars based in United States, China and Egypt. Fuwu Zhang's co-authors include Guocan Yu, Xiaohong Chen, Yijing Liu, Guizhi Zhu, Karen L. Wooley, Xiaoyuan Chen, Zhantong Wang, Zijian Zhou, Orit Jacobson and Gang Niu and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Fuwu Zhang

93 papers receiving 6.7k citations

Hit Papers

Activatable Singlet Oxygen Generation from Lipid Hydroper... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuwu Zhang United States 44 3.4k 2.6k 2.1k 1.9k 1.3k 94 6.7k
Haihua Xiao China 52 4.5k 1.3× 3.2k 1.2× 3.2k 1.6× 2.8k 1.5× 818 0.6× 175 9.5k
Jianbin Tang China 42 3.1k 0.9× 2.4k 0.9× 2.4k 1.2× 1.4k 0.7× 657 0.5× 142 6.8k
Xianzhu Yang China 51 5.7k 1.7× 3.8k 1.5× 3.7k 1.8× 2.5k 1.3× 856 0.6× 156 10.3k
Tianmeng Sun China 39 3.4k 1.0× 3.7k 1.4× 3.5k 1.7× 1.5k 0.8× 800 0.6× 112 8.2k
Jin‐Zhi Du China 42 4.7k 1.4× 5.0k 1.9× 3.3k 1.6× 1.4k 0.7× 1.2k 0.9× 97 8.9k
Xiuli Hu China 41 3.0k 0.9× 3.0k 1.2× 1.3k 0.7× 2.0k 1.0× 978 0.7× 129 6.7k
Yuanpei Li United States 38 2.9k 0.9× 2.8k 1.1× 2.1k 1.0× 1.2k 0.7× 688 0.5× 121 6.0k
Zhuxian Zhou China 48 4.8k 1.4× 4.3k 1.7× 3.9k 1.9× 1.8k 1.0× 718 0.5× 174 9.6k
Heebeom Koo South Korea 52 4.6k 1.4× 3.5k 1.3× 3.6k 1.7× 1.9k 1.0× 1.2k 0.9× 119 9.2k
Guping Tang China 50 2.2k 0.7× 2.5k 0.9× 3.3k 1.6× 1.8k 1.0× 1.6k 1.2× 202 7.8k

Countries citing papers authored by Fuwu Zhang

Since Specialization
Citations

This map shows the geographic impact of Fuwu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuwu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuwu Zhang more than expected).

Fields of papers citing papers by Fuwu Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuwu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuwu Zhang. The network helps show where Fuwu Zhang may publish in the future.

Co-authorship network of co-authors of Fuwu Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Fuwu Zhang. A scholar is included among the top collaborators of Fuwu Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuwu Zhang. Fuwu Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiao, et al.. (2025). Glutathione-Responsive Polyhomocysteine Derivatives with Ultralow Toxicity toward Therapeutic Delivery. Biomacromolecules. 26(11). 7470–7483.
3.
Zhang, Xiao, et al.. (2025). Polypeptide-protein conjugation: A new paradigm for therapeutic protein delivery. Journal of Controlled Release. 384. 113953–113953. 1 indexed citations
4.
Zhang, Wei, Nathan Smith, Mattia Bartoli, et al.. (2024). Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease. Acta Biomaterialia. 183. 341–355. 9 indexed citations
5.
Chen, Jiuyan, Fang Li, Jun Gu, et al.. (2023). Cancer cells inhibition by cationic carbon dots targeting the cellular nucleus. Journal of Colloid and Interface Science. 637. 193–206. 41 indexed citations
6.
Wang, Hai, et al.. (2023). Glucose‐derived superabsorbent hydrogel materials based on mechanically‐interlocked slide‐ring and triblock copolymer topologies. Journal of Polymer Science. 61(10). 937–950. 5 indexed citations
7.
Song, Yue, Mahmoud Elsabahy, Sarosh Khan, et al.. (2021). Morphologic Design of Silver-Bearing Sugar-Based Polymer Nanoparticles for Uroepithelial Cell Binding and Antimicrobial Delivery. Nano Letters. 21(12). 4990–4998. 34 indexed citations
8.
Lin, Yen‐Nan, Sarosh Khan, Yue Song, et al.. (2020). A Tale of Drug-Carrier Optimization: Controlling Stimuli Sensitivity via Nanoparticle Hydrophobicity through Drug Loading. Nano Letters. 20(9). 6563–6571. 19 indexed citations
9.
Lin, Yen‐Nan, Mahmoud Elsabahy, Sarosh Khan, et al.. (2020). Erythrocyte-Membrane-Camouflaged Nanocarriers with Tunable Paclitaxel Release Kinetics via Macromolecular Stereocomplexation. ACS Materials Letters. 2(6). 595–601. 10 indexed citations
10.
Li, Richen, Hai Wang, Yue Song, et al.. (2019). In Situ Production of Ag/Polymer Asymmetric Nanoparticles via a Powerful Light-Driven Technique. Journal of the American Chemical Society. 141(50). 19542–19545. 27 indexed citations
11.
Chen, Qingquan, Kush N. Shah, Fuwu Zhang, et al.. (2019). Minocycline and Silver Dual-Loaded Polyphosphoester-Based Nanoparticles for Treatment of Resistant Pseudomonas aeruginosa. Molecular Pharmaceutics. 16(4). 1606–1619. 22 indexed citations
12.
Su, Lu, Richen Li, Sarosh Khan, et al.. (2018). Chemical Design of Both a Glutathione-Sensitive Dimeric Drug Guest and a Glucose-Derived Nanocarrier Host to Achieve Enhanced Osteosarcoma Lung Metastatic Anticancer Selectivity. Journal of the American Chemical Society. 140(4). 1438–1446. 102 indexed citations
13.
Yu, Guocan, Xinlian Zhao, Jiong Zhou, et al.. (2018). Supramolecular Polymer-Based Nanomedicine: High Therapeutic Performance and Negligible Long-Term Immunotoxicity. Journal of the American Chemical Society. 140(25). 8005–8019. 270 indexed citations
14.
Zhang, Fuwu, Richen Li, Justin A. Smolen, et al.. (2017). Design and development of multifunctional polyphosphoester-based nanoparticles for ultrahigh paclitaxel dual loading. Nanoscale. 9(41). 15773–15777. 27 indexed citations
15.
Zhang, Fuwu, Shiyi Zhang, Richen Li, et al.. (2017). Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA. Drug Design Development and Therapy. Volume11. 483–496. 32 indexed citations
16.
17.
Su, Lu, Sarosh Khan, Jingwei Fan, et al.. (2017). Functional sugar-based polymers and nanostructures comprised of degradable poly(d-glucose carbonate)s. Polymer Chemistry. 8(10). 1699–1707. 58 indexed citations
18.
Wang, Hai, Lu Su, Richen Li, et al.. (2017). Polyphosphoramidates That Undergo Acid-Triggered Backbone Degradation. ACS Macro Letters. 6(3). 219–223. 31 indexed citations
19.
Wang, Zhantong, Yunlu Dai, Orit Jacobson, et al.. (2017). Metal ion assisted interface re-engineering of a ferritin nanocage for enhanced biofunctions and cancer therapy. Nanoscale. 10(3). 1135–1144. 31 indexed citations
20.
Li, Jing, Lianwen Zhang, Lin Lin, et al.. (2010). Isoforms of human O-GlcNAcase show distinct catalytic efficiencies. Biochemistry (Moscow). 75(7). 938–943. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026